JP7262227B2 - 被膜形成外用剤 - Google Patents

被膜形成外用剤 Download PDF

Info

Publication number
JP7262227B2
JP7262227B2 JP2018557441A JP2018557441A JP7262227B2 JP 7262227 B2 JP7262227 B2 JP 7262227B2 JP 2018557441 A JP2018557441 A JP 2018557441A JP 2018557441 A JP2018557441 A JP 2018557441A JP 7262227 B2 JP7262227 B2 JP 7262227B2
Authority
JP
Japan
Prior art keywords
film
oil
component
therapeutic agent
external preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018557441A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019082873A1 (ja
Inventor
勇樹 芦塚
孝彰 土肥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruho Co Ltd
Original Assignee
Maruho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruho Co Ltd filed Critical Maruho Co Ltd
Publication of JPWO2019082873A1 publication Critical patent/JPWO2019082873A1/ja
Application granted granted Critical
Publication of JP7262227B2 publication Critical patent/JP7262227B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2018557441A 2017-10-23 2018-10-23 被膜形成外用剤 Active JP7262227B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017204273 2017-10-23
JP2017204273 2017-10-23
PCT/JP2018/039294 WO2019082873A1 (fr) 2017-10-23 2018-10-23 Agent topique formant un revêtement

Publications (2)

Publication Number Publication Date
JPWO2019082873A1 JPWO2019082873A1 (ja) 2020-09-17
JP7262227B2 true JP7262227B2 (ja) 2023-04-21

Family

ID=66247447

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018557441A Active JP7262227B2 (ja) 2017-10-23 2018-10-23 被膜形成外用剤

Country Status (2)

Country Link
JP (1) JP7262227B2 (fr)
WO (1) WO2019082873A1 (fr)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000034218A (ja) 1998-07-17 2000-02-02 Shiseido Co Ltd 皮膚外用剤
JP2000063261A (ja) 1998-08-20 2000-02-29 Shiseido Co Ltd 皮膚外用剤
JP2005239678A (ja) 2004-02-27 2005-09-08 Hisamitsu Pharmaceut Co Inc 角質貯留性を高めた外用クリーム製剤
JP2006507285A (ja) 2002-10-25 2006-03-02 ヒル・デルマシューティカルズ・インコーポレーテッド 局所スキンケア組成物
WO2012011566A1 (fr) 2010-07-23 2012-01-26 マルホ株式会社 Composition crémeuse de type huile dans eau contenant du tacrolimus
JP2012031116A (ja) 2010-08-02 2012-02-16 Shiseido Co Ltd ウフェナマート含有皮膚外用剤
JP2012526738A (ja) 2009-05-12 2012-11-01 ガレニカ エービー モメタゾンとプロピレングリコールとの水中油型エマルジョン
JP2015199709A (ja) 2014-03-31 2015-11-12 小林製薬株式会社 皮膚外用組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01139525A (ja) * 1987-11-27 1989-06-01 Sanwa Kagaku Kenkyusho Co Ltd 外用フィルム製剤及びその製法
JP3670298B2 (ja) * 1992-07-20 2005-07-13 大鵬薬品工業株式会社 スルホニウム化合物含有皮膚外用剤
JP3454385B2 (ja) * 1993-10-15 2003-10-06 啓次郎 佐藤 Ｏ／ｗ型皮膚用クリームの製造方法
JP4336905B2 (ja) * 1997-12-19 2009-09-30 マルホ株式会社 硫酸化多糖類含有皮膚保湿乳剤性ローション剤
WO2013111817A1 (fr) * 2012-01-25 2013-08-01 マルホ株式会社 Composition crémeuse de type huile-dans-eau contenant du tacrolimus

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000034218A (ja) 1998-07-17 2000-02-02 Shiseido Co Ltd 皮膚外用剤
JP2000063261A (ja) 1998-08-20 2000-02-29 Shiseido Co Ltd 皮膚外用剤
JP2006507285A (ja) 2002-10-25 2006-03-02 ヒル・デルマシューティカルズ・インコーポレーテッド 局所スキンケア組成物
JP2005239678A (ja) 2004-02-27 2005-09-08 Hisamitsu Pharmaceut Co Inc 角質貯留性を高めた外用クリーム製剤
JP2012526738A (ja) 2009-05-12 2012-11-01 ガレニカ エービー モメタゾンとプロピレングリコールとの水中油型エマルジョン
WO2012011566A1 (fr) 2010-07-23 2012-01-26 マルホ株式会社 Composition crémeuse de type huile dans eau contenant du tacrolimus
JP2012031116A (ja) 2010-08-02 2012-02-16 Shiseido Co Ltd ウフェナマート含有皮膚外用剤
JP2015199709A (ja) 2014-03-31 2015-11-12 小林製薬株式会社 皮膚外用組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ヒルドイドクリーム０．３％、添付文書，2017年09月

Also Published As

Publication number Publication date
WO2019082873A1 (fr) 2019-05-02
JPWO2019082873A1 (ja) 2020-09-17

Similar Documents

Publication Publication Date Title
KR101930244B1 (ko) 국소용 코르티코스테로이드 조성물
US20070196453A1 (en) Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
WO2012011566A1 (fr) Composition crémeuse de type huile dans eau contenant du tacrolimus
WO2015075640A1 (fr) Formulation(s) pharmaceutique(s) stable (s) d'antibiotiques de la famille des tétracyclines
JP2008515911A (ja) 治療用のオルガノゲル調製物
CA2633472A1 (fr) Compositions de fluidification et procede pour administrer par voie cutanee des medicaments
AU2006326388A1 (en) Compositions and methods for treating dermatological conditions
CN110352052A (zh) 阿普斯特的局部治疗组合物
ES2875381T3 (es) Formulación tópica
CN103948518A (zh) 含有己脒定和维a类化合物的用于改善皮肤的组合物
CA2633464A1 (fr) Compositions et procedes d'administration dermique de medicaments
Tamarkin et al. Emollient foam in topical drug delivery
KR20230097052A (ko) 개선된 효능을 갖는 백반증 병변의 치료 방법
JPWO2016104618A1 (ja) 医療用皮膚外用剤
JP7262227B2 (ja) 被膜形成外用剤
CA3040867C (fr) Compositions halobetasol propionate
JP6275877B2 (ja) ヘパリンの局所製剤
JP5338030B2 (ja) アダパレン含有外用剤組成物
JP2023525160A (ja) 毛包内への生物活性剤の送達のための組成物
CN107613987A (zh) 糠酸莫米松的局部喷雾组合物
JP7512365B2 (ja) 油性外用液
WO2024057288A1 (fr) Méthodes de traitement de l'acné et de la peau grasse avec du tazarotène
JP5674786B2 (ja) タクロリムスを含有する水中油型クリーム状組成物
WO2024005726A1 (fr) Composition topique stable au stockage comprenant du clobétasol
WO2021119327A2 (fr) Administration transpore de cannabinoïdes et ses utilisations

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20211005

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211008

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20211005

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221012

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230210

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230403

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230411

R150 Certificate of patent or registration of utility model

Ref document number: 7262227

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150